These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 36821071)

  • 1. MicroRNA in lung cancer-a novel potential way for early diagnosis and therapy.
    Frydrychowicz M; Kuszel Ł; Dworacki G; Budna-Tukan J
    J Appl Genet; 2023 Sep; 64(3):459-477. PubMed ID: 36821071
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating epigenetic biomarkers in lung malignancies: From early diagnosis to therapy.
    Tomasetti M; Amati M; Neuzil J; Santarelli L
    Lung Cancer; 2017 May; 107():65-72. PubMed ID: 27312601
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identifying circulating miRNA biomarkers for early diagnosis and monitoring of lung cancer.
    Zhang YH; Jin M; Li J; Kong X
    Biochim Biophys Acta Mol Basis Dis; 2020 Oct; 1866(10):165847. PubMed ID: 32473385
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating microRNA-590-5p functions as a liquid biopsy marker in non-small cell lung cancer.
    Khandelwal A; Seam RK; Gupta M; Rana MK; Prakash H; Vasquez KM; Jain A
    Cancer Sci; 2020 Mar; 111(3):826-839. PubMed ID: 31520555
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blood-based liquid biopsy: Insights into early detection and clinical management of lung cancer.
    Liu C; Xiang X; Han S; Lim HY; Li L; Zhang X; Ma Z; Yang L; Guo S; Soo R; Ren B; Wang L; Goh BC
    Cancer Lett; 2022 Jan; 524():91-102. PubMed ID: 34656690
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating cell-free nucleic acids and platelets as a liquid biopsy in the provision of personalized therapy for lung cancer patients.
    Sorber L; Zwaenepoel K; Deschoolmeester V; Van Schil PE; Van Meerbeeck J; Lardon F; Rolfo C; Pauwels P
    Lung Cancer; 2017 May; 107():100-107. PubMed ID: 27180141
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liquid biopsy for early diagnosis of non-small cell lung carcinoma: recent research and detection technologies.
    Chang L; Li J; Zhang R
    Biochim Biophys Acta Rev Cancer; 2022 May; 1877(3):188729. PubMed ID: 35436521
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating MicroRNAs as Potential Biomarkers for Lung Cancer.
    Müller S; Janke F; Dietz S; Sültmann H
    Recent Results Cancer Res; 2020; 215():299-318. PubMed ID: 31605236
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Progress of Liquid Biopsy in Early Diagnosis of Lung Cancer].
    Song Z; Liu Y
    Zhongguo Fei Ai Za Zhi; 2018 Aug; 21(8):620-627. PubMed ID: 30172270
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potential clinical utility of liquid biopsy in early-stage non-small cell lung cancer.
    Shen H; Jin Y; Zhao H; Wu M; Zhang K; Wei Z; Wang X; Wang Z; Li Y; Yang F; Wang J; Chen K
    BMC Med; 2022 Dec; 20(1):480. PubMed ID: 36514063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cell-Free microRNAs as Potential Oral Cancer Biomarkers: From Diagnosis to Therapy.
    Rapado-González Ó; López-López R; López-Cedrún JL; Triana-Martínez G; Muinelo-Romay L; Suárez-Cunqueiro MM
    Cells; 2019 Dec; 8(12):. PubMed ID: 31861130
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liquid biopsies based on DNA methylation as biomarkers for the detection and prognosis of lung cancer.
    Li P; Liu S; Du L; Mohseni G; Zhang Y; Wang C
    Clin Epigenetics; 2022 Sep; 14(1):118. PubMed ID: 36153611
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liquid biopsy in lung cancer: significance in diagnostics, prediction, and treatment monitoring.
    Li W; Liu JB; Hou LK; Yu F; Zhang J; Wu W; Tang XM; Sun F; Lu HM; Deng J; Bai J; Li J; Wu CY; Lin QL; Lv ZW; Wang GR; Jiang GX; Ma YS; Fu D
    Mol Cancer; 2022 Jan; 21(1):25. PubMed ID: 35057806
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liquid Biopsy - Possibilities for Monitoring the Therapeutic Response in Non-Small Cell Lung Cancer.
    Raycheva GA; Ivanov HY; Grudeva-Popova ZG
    Folia Med (Plovdiv); 2021 Dec; 63(6):839-846. PubMed ID: 35851241
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liquid biopsy: miRNA as a potential biomarker in oral cancer.
    Mazumder S; Datta S; Ray JG; Chaudhuri K; Chatterjee R
    Cancer Epidemiol; 2019 Feb; 58():137-145. PubMed ID: 30579238
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of new techniques and clinical applications of liquid biopsy in lung cancer management.
    Chen K; He Y; Wang W; Yuan X; Carbone DP; Yang F
    Sci Bull (Beijing); 2024 May; 69(10):1556-1568. PubMed ID: 38641511
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating microRNA profiling in patients with advanced non-squamous NSCLC receiving bevacizumab/erlotinib followed by platinum-based chemotherapy at progression (SAKK 19/05).
    Joerger M; Baty F; Früh M; Droege C; Stahel RA; Betticher DC; von Moos R; Ochsenbein A; Pless M; Gautschi O; Rothschild S; Brauchli P; Klingbiel D; Zappa F; Brutsche M
    Lung Cancer; 2014 Aug; 85(2):306-13. PubMed ID: 24928469
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liquid Biopsy for Lung Cancer: Up-to-Date and Perspectives for Screening Programs.
    Casagrande GMS; Silva MO; Reis RM; Leal LF
    Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768828
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of circulating free DNA in the management of NSCLC.
    Esposito Abate R; Pasquale R; Fenizia F; Rachiglio AM; Roma C; Bergantino F; Forgione L; Lambiase M; Sacco A; Piccirillo MC; Morabito A; Normanno N
    Expert Rev Anticancer Ther; 2019 Jan; 19(1):19-28. PubMed ID: 30462523
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of Liquid Biopsy in the Care of Patients with Non-Small Cell Lung Cancer.
    Romero A; Serna-Blasco R; Calvo V; Provencio M
    Curr Treat Options Oncol; 2021 Aug; 22(10):86. PubMed ID: 34424428
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.